Vol 6 Issue 5

CELL AND GENE THERAPY INSIGHTS

June 2020 Issue

Vol 6 Issue 5

Download PDF

Featuring

Issue Spotlight: Clinical development strategy, tools and trial designs
Other articles

SPOTLIGHT

Clinical development strategy, tools and trial designs

Expert Insight

Cellular therapies for solid cancer: clinical experience, challenges and future revolution

Cellular therapies for solid cancer: clinical experience, challenges and future revolution

A Hasan, A Selvakumar, R O'Reilly et al.
1 July 2020
Read
Consideration of clinical translation of cardiac AAV gene therapy

Consideration of clinical translation of cardiac AAV gene therapy

Kelly P Yamada, Serena Tharakan, Kiyotake Ishikawa
14 May 2020
Read
Delivery methods for cardiovascular cell-based therapies: tools and clinical strategies

Delivery methods for cardiovascular cell-based therapies: tools and clinical strategies

Ruben A Alexanian, Amish N Raval
6 May 2020
Read
Clinical trial design in gene therapy for neurodegenerative diseases: Sanfilippo A syndrome

Clinical trial design in gene therapy for neurodegenerative diseases: Sanfilippo A syndrome

C R Plata-Salaman, A Morte, E Ortiz et al.
6 May 2020
Read

Interview

Progressing Bristol Myers Squibb’s clinical-stage pipeline of cellular cancer immunotherapies

Progressing Bristol Myers Squibb’s clinical-stage pipeline of cellular cancer immunotherapies

Stan Frankel
29 June 2020
Read
Targeting lung damage in COVID-19 patients with CD34+ cell therapy

Targeting lung damage in COVID-19 patients with CD34+ cell therapy

Douglas Losordo
17 June 2020
Read
A streamlined approach to biomarker development in cellular immunotherapy

A streamlined approach to biomarker development in cellular immunotherapy

Majid Ghoddusi
1 June 2020
Read

Journal articles

Research Article

The necessity of automated manufacture for cell-based immunotherapies: a cost-based analysis

The necessity of automated manufacture for cell-based immunotherapies: a cost-based analysis

R McCoy, J Hasan, S Ward et al.
10 June 2020
Read

Perspective

Regulatory considerations in the development of gene therapies for neurological disorders in the EU region: an industry perspective

Regulatory considerations in the development of gene therapies for neurological disorders in the EU region: an industry perspective

S Bennett, L Oliva, S Beattie et al.
30 July 2020
Read

Interview

Regulatory affairs in regen med: building trust, expediting development and navigating the impact of COVID-19

Regulatory affairs in regen med: building trust, expediting development and navigating the impact of COVID-19

Manal Morsy
10 July 2020
Read
The power of patient advocacy in connecting industry, academia and patients: the story of SLC6A1

The power of patient advocacy in connecting industry, academia and patients: the story of SLC6A1

Amber Freed
10 June 2020
Read

Commercial Insights

Cell & Gene Therapy Commercial Insight : April 2020

Cell & Gene Therapy Commercial Insight : April 2020

Mark Curtis, Richard Philipson
3 July 2020
Read